University of Minnesota. Driven to Discover.
The agency reports increased activity overall, 5 pediatric deaths, and a variant H1N1 infection in Iowa.
Rates of prevention of recurrent C diff were similar, with fewer side effects.
Japan-based Takeda announces the launch of a phase 1 trial of its Zika vaccine.
The strain resulted from a mix of high-path H5N8 and low-path H3N6.
Fever, crackling in the lungs, high pulse, and low blood oxygen may be predictive.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.